PepGen Inc. (PEPG)
NASDAQ: PEPG · Real-Time Price · USD
2.850
+0.440 (18.26%)
At close: Aug 7, 2026, 4:00 PM EDT
2.800
-0.050 (-1.75%)
Pre-market: Aug 10, 2026, 7:00 AM EDT
PepGen Employees
PepGen had 59 employees as of March 31, 2026. The number of employees decreased by 20 or -25.32% compared to the same quarter last year.
Employees
59
Change
-20
Growth
-25.32%
Revenue / Employee
n/a
Profits / Employee
-$1,219,339
Market Cap
197.13M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 59 | -20 | -25.32% |
| Dec 31, 2025 | 56 | -25 | -30.86% |
| Sep 30, 2025 | 57 | -19 | -25.00% |
| Jun 30, 2025 | 62 | -10 | -13.89% |
| Mar 31, 2025 | 79 | 14 | 21.54% |
| Dec 31, 2024 | 81 | 17 | 26.56% |
| Sep 30, 2024 | 76 | 13 | 20.63% |
| Jun 30, 2024 | 72 | 18 | 33.33% |
| Mar 31, 2024 | 65 | 16 | 32.65% |
| Dec 31, 2023 | 64 | 19 | 42.22% |
| Sep 30, 2023 | 63 | 23 | 57.50% |
| Jun 30, 2023 | 54 | 18 | 50.00% |
| Mar 31, 2023 | 49 | 18 | 58.06% |
| Dec 31, 2022 | 45 | 14 | 45.16% |
| Sep 30, 2022 | 40 | 17 | 73.91% |
| Jun 30, 2022 | 36 | 24 | 200.00% |
| Mar 31, 2022 | 31 | 19 | 158.33% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| Protalix BioTherapeutics | 226 |
| Humacyte | 184 |
| Coherus Oncology | 145 |
| Voyager Therapeutics | 141 |
| Alector | 103 |
| Immunic | 95 |
| Alpha Cognition | 71 |
PEPG News
- 3 days ago - PepGen reports Q2 EPS (26c), consensus (29c) - TheFly
- 3 days ago - PepGen to advance PGN-EDODM1 into highest dose cohort - TheFly
- 3 days ago - PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights - Business Wire
- 3 days ago - PepGen to Advance PGN-EDODM1 Into Highest Dose Cohort in Phase 2 FREEDOM2-DM1 Study Following DSMB Review - Business Wire
- 4 days ago - PepGen Quarterly report: Q2 2026 - Filings
- 4 days ago - PepGen Earnings release: Q2 2026 - Filings
- 4 days ago - PepGen Slides: Company presentation - Filings
- 7 weeks ago - Craig-Hallum bullish on PepGen, initiates with a Buy - TheFly